UPS Healthcare amplía las capacidades de la cadena de frío en Europa con una nueva instalación en Roma
MARCH 23, 2021 | 3-MIN READ
UPS anuncia que está comenzando la construcción de una nueva instalación de logística sanitaria a medida de 40,000 pies cuadrados en Roma, Italia.
ATLANTA – UPS (NYSE: UPS) today announced it is breaking ground on a new 40,000 square meter built-to-suit healthcare logistics facility in Rome, Italy. La inauguración de esta instalación validada y conforme con la buenas prácticas de fabricación (GMP) está programada para julio de 2022, e incluirá varios entornos validados de temperatura controlada para productos sanitarios que requieran almacenamiento a temperaturas de -20 C a -80 C, 2 C a 8 C y 15 C a 25 C.
The facility will support pharmaceutical and medical device customers in Italy and will provide another direct link from Europe to UPS's global network.
"We continue to expand our industry leading cold chain capabilities in the European market," said Wes Wheeler, president of UPS Healthcare. "Our new facility in Rome will service the growth needs of our healthcare clients in a country that manufactures many of the world's most important sterile pharmaceuticals."
When combined with UPS Healthcare's active temperature-controlled delivery services, this latest expansion highlights the company's position as the provider of choice for end-to-end cold chain distribution and transportation.
"Our experience moving critical healthcare shipments, including COVID-19 vaccines, means that more of our clients are looking to us for solutions," said Kate Gutmann, UPS chief sales and solutions officer, and senior vice president, UPS Global Healthcare. "We're investing heavily in our global cold chain so we can continue to be a market leader in this space."
This expansion, in addition to facility investments in Singapore, Shanghai, Australia and several key markets in the United States, is another step in implementing UPS Healthcare's strategy. UPS's recent investments also include: una nueva instalación de vanguardia conforme con las GMP en Birmingham, Reino Unido; un nuevo almacén en la República Checa; expansión de la cadena de frío y una granja de congeladores en Roermond, Países Bajos; y una segunda instalación central conforme con las GMP cerca de Varsovia, Polonia.
La empresa opera ahora 125 instalaciones conformes con las GDP/GMP en 34 países de todo el mundo.
UPS Healthcare continúa proporcionando amplios servicios que abordan toda la gama de necesidades logísticas, desde espacio de distribución con licencia sanitaria hasta gestión de la cadena de suministro, creación de kits y embalaje y distribución de dispositivos médicos, muestras de ensayos clínicos y de laboratorio. The company's global infrastructure, monitoring and tracking capabilities, and private data protection make UPS Healthcare a best-in-class supply chain expert that remains flexible, agile and responsive to myriad logistics demands.
Acerca de UPS Healthcare
UPS Healthcare delivers unparalleled healthcare logistics expertise to its customers around the world. UPS Healthcare has 11+ million square feet of cGMP and GDP-compliant healthcare distribution space globally. Services include inventory management, cold chain packaging and shipping, storage and fulfillment of medical devices, and lab and clinical trial logistics. UPS Healthcare's global infrastructure, its UPS® Premier visibility service, its track and trace technology, and its global quality system are well-suited to meet today's complex logistics demands for the pharmaceutical, medical device, and laboratory diagnostic industries.
Recent Healthcare News
UPS Healthcare accelerates cold chain capabilities
UPS Healthcare™ Cold Chain brings a full suite of end-to-end cold chain capabilities to customers worldwide.
UPS Healthcare opens first dedicated facility in Germany
Strategically located, the new facility in Giessen offers access to the fast-growing European healthcare markets.
UPS Healthcare unveils new logistics facility in Singapore
The new 8,700 square meter facility is strategically located to support growth of Singapore’s main biomedical manufacturing cluster.